Many studies have demonstrated that augmented HIF-1α signalling is protective in the context of MI and leads to improved heart contractility, angiogenesis and reduced infarct size93,94; however, chronic activation of HIF-1α signalling in the long term may exacerbate adverse cardiac remodelling and advance progression to heart failure.95–97. Here, HIF1A is linked to myocardial infarction.